Related Experiment Video
Updated: May 22, 2026

12:22
The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Current evidence and future directions for KIM-1 as a blood-based biomarker in RCC
Wenxin Xu1,2, Joseph V Bonventre3,4,5, Toni K Choueiri6,3
1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Wenxin_Xu1@dfci.harvard.edu.
Nature Reviews. Clinical Oncology
|May 20, 2026
Summary
No abstract available in PubMed .
